Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength?
09:40am, Thursday, 10'th Apr 2025
Bio-Techne (TECH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase
CMB.TECH publishes its annual report and submits Form 20-F for the year ended 31 December 2024
02:09am, Thursday, 10'th Apr 2025
Antwerp, April 10, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) published its annual report in accordance with Belgian law for the year ende
MINNEAPOLIS , April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnost
Bio-Techne Opens New Customer Experience Centre in Germany
11:01am, Monday, 31'st Mar 2025
TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.
CMB.TECH announces final year results
05:07pm, Thursday, 27'th Mar 2025
CMB.TECH ANNOUNCES FINAL YEAR RESULTS TRANSFORMATIONAL YEAR AND STRONG EARNINGS ANTWERP, Belgium, 27 March 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
07:00am, Wednesday, 26'th Mar 2025
MINNEAPOLIS , March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the E
MINNEAPOLIS , March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by l
CMB.TECH and MOL sign landmark agreement for nine ammonia-powered vessels
05:30am, Monday, 24'th Mar 2025
Antwerp, March 24, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) is pleased to announce that it has signed an agreement with Mi
TECH Stock Might Rise Following the Leo Shipping Announcement
08:00am, Wednesday, 12'th Mar 2025
Bio-Techne begins to ship the Leo System - the next-generation high throughput simple western platform.
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
07:00am, Monday, 10'th Mar 2025
MINNEAPOLIS , March 10, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands up
CMB.TECH acquires Hemen's shares in Golden Ocean – Disclosure of large shareholdings
05:30pm, Tuesday, 04'th Mar 2025
ANTWERP, Belgium, 4 March, 2025 - CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH”) today announced that it, through its wholly-owned subsidiary, CMB.TECH Bermuda Ltd., has entered into a sha
Hemen sells stake in Golden Ocean to CMB.TECH
05:30pm, Tuesday, 04'th Mar 2025
Limassol, Cyprus, March 4, 2025 – Hemen Holding Limited (“Hemen”) today announced that it has entered into an agreement to sell 81,363,730 shares in Golden Ocean Group Limited (NASDAQ/OSE: GOGL)
CMB.TECH buys Hemen stake in Golden Ocean
04:25pm, Tuesday, 04'th Mar 2025
Belgium, March 04, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) is pleased to announce that it has entered into a share purchase agreement w
TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain?
08:05am, Tuesday, 04'th Mar 2025
Bio-Techne's Asuragen brand inks a partnership with Oxford Nanopore Technologies to launch research-use-only AmplideX Nanopore Carrier Plus Kit.
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
07:00am, Monday, 03'rd Mar 2025
AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England , March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) to
